Journal article icon

Journal article

Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain.

Abstract:
RATIONALE: Acute depletion of brain tyrosine using a tyrosine-free amino acid mixture offers a nutritional approach to reduce central catecholamine function. Recent preclinical data suggest that tyrosine-free amino acid mixtures may have region-specific effects through targeting dopamine neurones. OBJECTIVES: Here we used fos immunocytochemistry to examine the neuroanatomical sites of action of a tyrosine-free amino acid mixture administered either alone or combined with amphetamine. METHODS: Rats (male, Sprague Dawley, 240-260 g) were administered (IP) either a tyrosine-free amino acid mixture (1 g/kg), or the same mixture supplemented with tyrosine and phenylalanine (1 g/kg). Mixtures were injected twice (1 h apart) followed 1 h later by amphetamine (2 mg/kg SC). Two hours later, cardiac perfusion was performed and brains were processed for fos immunocytochemistry. Fos positive cells were counted using computer imaging software. RESULTS: The tyrosine-free amino acid mixture alone did not alter fos expression in ten regions of the rat forebrain compared to saline controls. However, the mixture reduced the increase in fos expression evoked by amphetamine. This effect was region-specific and was greatest in caudate putamen, nucleus accumbens, bed nucleus stria terminalis and lateral habenula, and lacking in other areas including cingulate and insular cortices, lateral septum and central amygdaloid nucleus. Moreover, in most regions the effect of the tyrosine-free mixture was less after tyrosine and phenylalanine supplementation. CONCLUSIONS: In summary, a tyrosine-free amino acid mixture reduced amphetamine-induced fos expression but this effect was region-specific and included dopamine-rich regions. These data further support the idea that tyrosine depletion strategies have potential as treatments for mania and other hyperdopaminergic states.
Publication status:
Published

Actions

Access Document

Publisher copy:
10.1007/s00213-003-1607-7

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Pharmacology
Role:
Author


Journal:
Psychopharmacology More from this journal
Volume:
171
Issue:
4
Pages:
435-440
Publication date:
2004-02-01
DOI:
EISSN:
1432-2072
ISSN:
0033-3158


Language:
English
Keywords:
Pubs id:
pubs:185242
UUID:
uuid:e8a4b6e5-447d-4d37-aa9b-9768da1ebe05
Local pid:
pubs:185242
Source identifiers:
185242
Deposit date:
2012-12-19
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP